Xcelerate (OTCMKTS:XCRT – Get Free Report) and Chemed (NYSE:CHE – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation and dividends.
Valuation and Earnings
This table compares Xcelerate and Chemed”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Xcelerate | N/A | N/A | N/A | N/A | N/A |
| Chemed | $2.53 billion | 2.21 | $265.24 million | $18.37 | 20.87 |
Profitability
This table compares Xcelerate and Chemed’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Xcelerate | N/A | N/A | N/A |
| Chemed | 10.48% | 25.66% | 17.24% |
Volatility & Risk
Xcelerate has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Xcelerate and Chemed, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Xcelerate | 0 | 0 | 0 | 0 | 0.00 |
| Chemed | 2 | 2 | 2 | 0 | 2.00 |
Chemed has a consensus price target of $498.00, suggesting a potential upside of 29.88%. Given Chemed’s stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Xcelerate.
Insider and Institutional Ownership
95.9% of Chemed shares are held by institutional investors. 3.3% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Chemed beats Xcelerate on 9 of the 10 factors compared between the two stocks.
About Xcelerate
Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health technology to assist patients; owning and licensing the rights to various forms of medical equipment. It also provides Ceramedx, a natural plant based therapeutic skin care product; Earth Science Beauty, which offers natural facial skincare targeted to specific skin types. The company was formerly known as Union Dental Holdings, Inc. and changed its name to Xcelerate Inc. Xcelerate Inc. was incorporated in 1996 is based in Mauldin, South Carolina.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Receive News & Ratings for Xcelerate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xcelerate and related companies with MarketBeat.com's FREE daily email newsletter.
